Weight change in monozygotic twins treated with valproate

Obesity Research

Volumn 13, Issue 8, 2005, Pages 1330-1334

  Klein, Karl Martin ^a   Hamer, Hajo M ^a   Reis, Janine ^a   Schmidtke, Jörg ^b   Oertel, Wolfgang H ^a   Theisen, Frank M ^a   Hebebrand, Johannes ^a   Rosenow, Felix ^a  

^a PHILIPPS UNIVERSITY MARBURG   (Germany)

^b HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

Adverse effects; Anticonvulsive agents; Heredity; Weight gain

Indexed keywords

ANTICONVULSIVE AGENT; VALPROIC ACID;

ADOLESCENT; ADULT; ARTICLE; CASE REPORT; DRUG EFFECT; EPILEPSY; FEMALE; GENETICS; HUMAN; MALE; MONOZYGOTIC TWINS; OBESITY; PATHOLOGY; PRESCHOOL CHILD; RISK FACTOR; TWINS; WEIGHT GAIN;

ADOLESCENT; ADULT; ANTICONVULSANTS; CHILD, PRESCHOOL; DISEASES IN TWINS; EPILEPSY; FEMALE; HUMANS; MALE; OBESITY; RISK FACTORS; TWINS, MONOZYGOTIC; VALPROIC ACID; WEIGHT GAIN;

EID: 32944473060     PISSN: 10717323     EISSN: None     Source Type: Journal    
DOI: 10.1038/oby.2005.161     Document Type: Article

References (27)

1. Mattson RH, Cramer JA, Collins JF. A comparison of valproate with carbamazepine for the treatment of complex partial seizures and secondarily generalized tonic-clonic seizures in adults. The Department of Veterans Affairs Epilepsy Cooperative Study No. 264 Group. N Engl J Med. 1992;327: 765-71.
2. Isojarvi JI, Laatikainen TJ, Knip M, Pakarinen AJ, Juntunen KT, Myllyla VV. Obesity and endocrine disorders in women taking valproate for epilepsy. Ann Neural. 1996;39: 579-84.
3. Dinesen H, Gram L, Andersen T, Dam M. Weight gain during treatment with valproate. Acta Neural Scand. 1984;70: 65-9.
4. Egger J, Brett EM. Effects of sodium valproate in 100 children with special reference to weight. Br Med J (Clin Res Ed). 1981;283:577-81.
5. Biton V, Mirza W, Montouris G, Vuong A, Hammer AE, Barrett PS. Weight change associated with valproate and lamotrigine monotherapy in patients with epilepsy. Neurology. 2001;56:172-7.
6. Biton V, Levisohn P, Hoyler S, Vuong A, Hammer AE. Lamotrigine versus valproate monotherapy-associated weight change in adolescents with epilepsy: results from a post hoc analysis of a randomized, double-blind clinical trial. J Child Neurol. 2003;18:133-9.
7. Wirrell EC. Valproic acid-associated weight gain in older children and teens with epilepsy. Pediatr Neurol. 2003;28: 126-9.
8. Novak GP, Maytal J, Alshansky A, Eviatar L, Sy-Kho R, Siddique Q. Risk of excessive weight gain in epileptic children treated with valproate. J Child Neurol. 1999;14: 490-5.
9. Jallon P, Picard F. Bodyweight gain and anticonvulsants: a comparative review. Drug Saf. 2001;24:969-78.
10. Verrotti A, Basciani F, Morresi S, de Martino M, Morgese G, Chiarelli F. Serum leptin changes in epileptic patients who gain weight after therapy with valproic acid. Neurology. 1999; 53:230-2.
11. Verrotti A, Basciani F, De Simone M, Trotta D, Morgese G, Chiarelli F. Insulin resistance in epileptic girls who gain weight after therapy with valproic acid. J Child Neurol. 2002; 17:265-8.
12. Corman CL, Leung NM, Guberman AH. Weight gain in epileptic patients during treatment with valproic acid: a retrospective study. Can J Neurol Sci. 1997;24:240-4.
13. Pijl H, Meinders AE. Bodyweight change as an adverse effect of drug treatment. Mechanisms and management. Drug Saf. 1996;14:329-42.
14. Pylvanen V, Knip M, Pakarinen A, Kotila M, Turkka J, Isojarvi JI. Serum insulin and leptin levels in valproate-associated obesity. Epilepsia. 2002;43:514-7.
15. Luef G, Abraham I, Hoppichler F, et al. Increase in post-prandial serum insulin levels in epileptic patients with valproic acid therapy. Metabolism. 2002;51:1274-8.
16. Isojarvi JI, Rattya J, Myllyla VV, et al. Valproate, lamotrigine, and insulin-mediated risks in women with epilepsy. Ann Neurol. 1998;43:446-51.
17. Demir E, Aysun S. Weight gain associated with valproate in childhood. Pediatr Neurol. 2000;22:361-4.
18. Theisen FM, Cichon S, Linden A, Martin M, Remschmidt H, Hebebrand J. Clozapine and weight gain. Am J Psychiatry. 2001; 158:816.
19. Wehmeier PM, Gebhardt S, Schmidtke J, Remschmidt H, Hebebrand J, Theisen FM. Clozapine: weight gain in a pair of monozygotic twins concordant for schizophrenia and mild mental retardation. Psychiatry Res. 2005;133:273-6.
20. Kromeyer-Hauschild K, Wabitsch M, Kunze D, et al. Percentiles of body mass index in children and adolescents evaluated from different regional german studies. Monatsschr Kinderheilkd. 2001;149:807-18.
21. Pietilainen KH, Kaprio J, Rasanen M, Rissanen A, Rose RJ. Genetic and environmental influences on the tracking of body size from birth to early adulthood. Obes Res. 2002;10: 875-84.
22. Loos RJ, Beunen G, Fagard R, Derom C, Vlietinck R. Birth weight and body composition in young adult men - a prospective twin study, Int J Obes Relat Metab Disord. 2001;25: 1537-45.
23. Luke B, Leurgans S, Keith L, Keith D. The childhood growth of twin children. Acta Genet Med Gemellol (Roma). 1995:44:169-78.
24. Wilson RS. Twin growth: initial deficit, recovery, and trends in concordance from birth to nine years. Ann Hum Biol. 1979:6:205-20.
25. Ooki S, Asaka A. Physical growth of Japanese twins. Acta Genet Med Gemellol (Roma). 1993:42:275-87.
26. Hakala P, Rissanen A, Koskenvuo M, Kaprio J, Ronnemaa T. Environmental factors in the development of obesity in identical twins, Int J Obes Relat Metab Disord. 1999:23:746-53.
27. Hebebrand J, Friedel S, Schauble N, Geller F, Hinney A. Perspectives: molecular genetic research in human obesity. Obes Rev. 2003:4:139-46.